NCT02345356View on ClinicalTrials.gov

A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

May 17, 2022

Study Completion Date

May 17, 2022

Conditions
Atrial FibrillationDeep Vein ThrombosisCardiac Valvular InsufficiencyCoagulopathiesPulmonary Embolism
Interventions
GENETIC

Genotype-guided

Individual warfarin dose adjustments by using a pharmacogenetically driven algorithm

OTHER

Standard-of-Care

Individual warfarin dose adjustments by using a clinically driven algorithm (standard care)

Trial Locations (3)

33125

Miami VA Healthcare System, Miami

00984

UPR University Hospital at Carolina, Carolina

00936

UDH University Hospital at Centro Medico, San Juan

Sponsors

Collaborators (1)

Genomas, Inc
All Listed Sponsors
collaborator

National Institute on Minority Health and Health Disparities (NIMHD)

NIH

collaborator

Genomas, Inc

INDUSTRY

lead

University of Puerto Rico

OTHER

NCT02345356 - A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics | Biotech Hunter | Biotech Hunter